These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7494860)

  • 1. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
    Fromenty B; Pessayre D
    Pharmacol Ther; 1995; 67(1):101-54. PubMed ID: 7494860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines.
    Fromenty B; Pessayre D
    J Hepatol; 1997; 26 Suppl 2():43-53. PubMed ID: 9204409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of mitochondria in drug-induced liver injury.
    Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
    Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
    Le Dinh T; Freneaux E; Labbe G; Letteron P; Degott C; Geneve J; Berson A; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1988 Nov; 247(2):745-50. PubMed ID: 3183967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity due to mitochondrial dysfunction.
    Pessayre D; Mansouri A; Haouzi D; Fromenty B
    Cell Biol Toxicol; 1999; 15(6):367-73. PubMed ID: 10811531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in drug-induced liver injury.
    Pessayre D; Mansouri A; Berson A; Fromenty B
    Handb Exp Pharmacol; 2010; (196):311-65. PubMed ID: 20020267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
    Begriche K; Massart J; Robin MA; Borgne-Sanchez A; Fromenty B
    J Hepatol; 2011 Apr; 54(4):773-94. PubMed ID: 21145849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
    Fromenty B; Fisch C; Labbe G; Degott C; Deschamps D; Berson A; Letteron P; Pessayre D
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1371-6. PubMed ID: 2124623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
    Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
    Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of mitochondrial DNA homeostasis in drug-induced liver injury.
    Fromenty B
    Food Chem Toxicol; 2020 Jan; 135():110916. PubMed ID: 31669601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvesicular steatosis of the liver.
    Hautekeete ML; Degott C; Benhamou JP
    Acta Clin Belg; 1990; 45(5):311-26. PubMed ID: 2177300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to development of acute fatty liver of pregnancy.
    Grimbert S; Fromenty B; Fisch C; Letteron P; Berson A; Durand-Schneider AM; Feldmann G; Pessayre D
    Hepatology; 1993 Apr; 17(4):628-37. PubMed ID: 8477967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
    van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
    Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic.
    Fréneaux E; Labbe G; Letteron P; The Le Dinh ; Degott C; Genève J; Larrey D; Pessayre D
    Hepatology; 1988; 8(5):1056-62. PubMed ID: 3417225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
    Vickers AE; Bentley P; Fisher RL
    Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.
    Berson A; De Beco V; Lettéron P; Robin MA; Moreau C; El Kahwaji J; Verthier N; Feldmann G; Fromenty B; Pessayre D
    Gastroenterology; 1998 Apr; 114(4):764-74. PubMed ID: 9516397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy.
    Grimbert S; Fisch C; Deschamps D; Berson A; Fromenty B; Feldmann G; Pessayre D
    Am J Physiol; 1995 Jan; 268(1 Pt 1):G107-15. PubMed ID: 7840191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of the mitochondria.
    Treem WR; Sokol RJ
    Semin Liver Dis; 1998; 18(3):237-53. PubMed ID: 9773424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals.
    Buron N; Porceddu M; Loyant R; Martel C; Allard JA; Fromenty B; Borgne-Sanchez A
    Toxicol Sci; 2024 Aug; 200(2):369-381. PubMed ID: 38676573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.